Company Number: 13804603

Analysis Date: 2025-07-29 19:03 UTC

Financial Health Assessment for AS SHOPFITTING LTD (as of 31 December 2024)

---

1. Financial Health Score: B

Explanation:
AS Shopfitting Ltd shows solid financial improvement and stability over recent years, demonstrating healthy asset growth and strong working capital. However, the introduction of long-term liabilities and a relatively small asset base compared to larger peers prevent a top-grade score. The company's financial condition is good, with no immediate distress signals, but there is room for cautious management of debt levels and asset utilization.

---

2. Key Vital Signs

Metric	2024 Value	Interpretation
Fixed Assets	£21,844	Increased significantly, indicating investment in long-term resources.
Current Assets	£88,539	Healthy liquidity, sufficient short-term resources to meet obligations.
Current Liabilities	£15,051	Short-term obligations reduced substantially from prior years, improving liquidity.
Net Current Assets (Working Capital)	£73,488	Strong positive working capital signals good short-term financial health and operational liquidity.
Long-term Liabilities	£30,600	Newly introduced long-term debt; manageable but requires monitoring.
Net Assets (Equity)	£64,732	Growth from £39,799 in 2023 to £64,732 in 2024 reflects retained earnings and asset growth, signaling increased shareholder value.
Shareholders' Funds	£64,732	Equity backing is stable and improving, providing a buffer against losses.

---

3. Diagnosis: Financial "Health" Check

• Cardiovascular System (Liquidity & Cash Flow):
  The company exhibits a healthy pulse with strong net current assets (£73,488), indicating ample liquidity to cover short-term liabilities. The reduction of current liabilities from £29,482 to £15,051 strengthens this liquidity "heartbeat."

• Skeletal System (Asset Structure):
  The fixed assets have nearly doubled from £1,125 to £21,844, showing investment in the company’s operational infrastructure. This "bone structure" is solidifying, but care must be taken to ensure these assets are productive and not over-leveraged.

• Respiratory System (Solvency & Leverage):
  Introduction of £30,600 in long-term liabilities suggests the company has taken on external financing. While this can be beneficial for growth, it introduces a "breathing challenge"—the company must ensure it can service this debt comfortably.

• Nervous System (Management & Control):
  The sole director and significant shareholder, Mr. Arron Shons, controls the company fully, indicating centralized decision-making. This can be efficient but also poses concentration risk.

• Symptoms of Distress:
  No overdue filings, no signs of liquidity crunch, and increasing equity indicate the company is not currently under financial distress.

---

4. Recommendations: Prescriptions for Financial Wellness

1. Monitor Debt Servicing Capacity:
   The new long-term liabilities should be regularly evaluated against cash flows to avoid overextension. Consider stress-testing cash flows under various scenarios.

2. Asset Utilization Review:
   Ensure the newly acquired fixed assets are effectively contributing to revenue and profit generation. Underutilized assets can tie up capital unnecessarily.

3. Maintain Strong Working Capital:
   Continue to manage receivables, payables, and inventory carefully to sustain the healthy net current assets position.

4. Diversify Management Input:
   While centralized control has benefits, consider expanding the management team or advisory board to add diverse perspectives and reduce single-person risk.

5. Prepare for Growth Opportunities:
   With a solid balance sheet, the company is well-positioned to pursue new contracts or market expansion. Strategic investments should be balanced against maintaining financial stability.

---